首站-论文投稿智能助手
典型文献
GPCR-mediated EGFR transactivation ameliorates skin toxicities induced by afatinib
文献摘要:
Many G-protein-coupled receptor(GPCR)agonists have been studied for transactivating epidermal growth factor receptor(EGFR)signaling through extracellular or intracellular pathways.Accumulated evidence has confirmed that GPCR transactivation participates in various diseases.However,the clinical application of GPCR transactivation has not been explored,and more translational studies are needed to develop therapies to target GPCR-mediated EGFR transactivation.In cancer patients treated with EGFR inhibitors(EGFRi),especially afatinib,a unique acneiform rash is frequently developed.In this study,we first established the connection between GPCR transactivation and EGFRi-induced skin disease.We examined the ability of three different GPCR agonists to reverse signaling inhibition and ameliorate rash induced by EGFRi.The activation of different agonists follows unique time and kinase patterns.Rats treated with EGFRi show a similar skin phenotype,with rash occurring in the clinic;correspondingly,treatment with GPCR agonists reduced keratinocyte apoptosis,growth retardation and infiltration of inflammatory cytokines by transactivation.This phenomenon demonstrates that EGFR inhibition in keratinocytes regulates key factors associated with rash.Our findings indicate that maintaining EGFR signaling by GPCR agonists might provide a possible therapy for EGFR inhibitor-induced skin toxicities.Our study provides the first example of the translational application of GPCR transactivation in treating diseases.
文献关键词:
作者姓名:
Le-ying Chen;Qing You;Da-zhao Lv;Shuai-hu Li;Shi-yi Zhang
作者机构:
School of Biomedical Engineering,Shanghai Jiao Tong University,Shanghai 200240,China
引用格式:
[1]Le-ying Chen;Qing You;Da-zhao Lv;Shuai-hu Li;Shi-yi Zhang-.GPCR-mediated EGFR transactivation ameliorates skin toxicities induced by afatinib)[J].中国药理学报(英文版),2022(06):1534-1543
A类:
afatinib,transactivating,EGFRi,acneiform
B类:
GPCR,mediated,transactivation,ameliorates,skin,toxicities,induced,by,Many,protein,coupled,receptor,agonists,have,been,studied,epidermal,growth,signaling,through,extracellular,intracellular,pathways,Accumulated,evidence,has,confirmed,that,participates,various,diseases,However,clinical,application,explored,more,translational,studies,are,needed,therapies,target,In,cancer,patients,treated,inhibitors,especially,unique,rash,frequently,developed,this,study,first,established,connection,between,We,examined,ability,three,different,reverse,inhibition,follows,kinase,patterns,Rats,show,similar,phenotype,occurring,correspondingly,treatment,reduced,apoptosis,retardation,infiltration,inflammatory,cytokines,This,phenomenon,demonstrates,keratinocytes,regulates,key,factors,associated,Our,findings,indicate,maintaining,might,possible,therapy,provides,example,treating
AB值:
0.471709
相似文献
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Ming Bai;Meng Wang;Ting Deng;Yuxian Bai;Kai Zang;Zhanhui Miao;Wenlin Gai;Liangzhi Xie;Yi Ba-Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Tianjin's Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin 300060,China;Department of Gastrointestinal Oncology,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Medical Oncology,Henan Cancer Hospital,The Affiliated Cancer Hospital of Zhengzhou University,Zhengzhou 450008,China;Oncology Department,The First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China;Sinocelltech Ltd.,Beijing 100176,China;Beijing Engineering Research Center of Protein and Antibody,Beijing 100176,China;Cell Culture Engineering Center,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100176,China
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/ BRAF/TAK1/ERK/ETV4 signaling
Panpan Ma;Xinxin Jin;Zhiwei Fan;Zhou Wang;Suhui Yue;Changyue Wu;Shiyin Chen;Yuanyuan Wu;Miaomiao Chen;Donghua Gu;Siliang Zhang;Renfang Mao;Yihui Fan-Laboratory of Medical Science,School of Medicine,Nantong University,Nantong 226001,China;Department of Pathogenic Biology,School of Medicine,Nantong University,Nantong 226001,China;Department of Clinical Laboratory,Yancheng No.1 People's Hospital,Yancheng 224005,China;School of Life Sciences,Nantong University,Nantong 226001,China;Department of Dermatology,Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Urology,the Second Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Radiotherapy Oncology,Harbin Medical University Cancer Hospital,Harbin 150086,China;Department of Pathophysiology,School of Medicine,Nantong University,Nantong 226001,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Bradykinin postconditioning protects rat hippocampal neurons after restoration of spontaneous circulation following cardiac arrest via activation of the AMPK/mTOR signaling pathway
Shi-Rong Lin;Qing-Ming Lin;Yu-Jia Lin;Xin Qian;Xiao-Ping Wang;Zheng Gong;Feng Chen;Bin Song-Provincial College of Clinical Medicine,Fujian Medical University,Fuzhou,Fujian Province,China;Department of Emergency,Fujian Provincial Hospital South Branch,Fuzhou,Fujian Province,China;Department of Emergency,Fujian Provincial Hospital,Fuzhou,Fujian Province,China;Fujian Emergency Medical Center,Fuzhou,Fujian Province,China;Fujian Provincial Key Laboratory of Emergency Medicine,Fuzhou,Fujian Province,China;Department of Human Anatomy,School of Basic Medical Sciences,Fujian Medical University, Fuzhou,Fujian Province,China;Key Laboratory of Brain Aging and Neurodegenerative Diseases of Fujian Province,Fuzhou,Fujian Province,China;Laboratory of Clinical Applied Anatomy,Fujian Medical University,Fuzhou,Fujian Province,China
Molecular insights into ligand recognition and G protein coupling of the neuromodulatory orphan receptor GPR139
Yali Zhou;Henrik Daver;Boris Trapkov;Lijie Wu;Meng Wu;Kasper Harps?e;Patrick R.Gentry;Kaiwen Liu;Marina Larionova;Junlin Liu;Na Chen;Hans Br(a)uner-Osborne;David E.Gloriam;Tian Hua;Zhi-Jie Liu-iHuman Institute,ShanghaiTech University,Shanghai,China;School of Life Science and Technology,ShanghaiTech University,Shanghai,China;University of Chinese Academy of Sciences,Beijing,China;CAS Center for Excellence in Molecular Cell Science,Shanghai Institute of Biochemistry and Cell Biology,Chinese Academy of Sciences,Shanghai,China;Department of Drug Design and Pharmacology,University of Copenhagen,Universitetsparken 2,Copenhagen,Denmark;Photobiology laboratory,Institute of Biophysics SB RAS,Federal Research Center "Krasnoyarsk Science Center SB RAS",Akademgorodok 50/50,Krasnoyarsk,Russia
EGFR signaling promotes nuclear translocation of plasma membrane protein TSPAN8 to enhance tumor progression via STAT3-mediated transcription
Xiaoqing Lu;Liwei An;Guangjian FanTi;Lijuan Zang;Weiyi Huang;Junjian Li;Jun Liu;Weiyu Ge;Yuwei Huang;Jingxuan Xu;Shaoqian Du;Yuan Cao;Tianhao Zhou;Huijing Yin;Li Yu;Shi Jiao;Hongxia Wang-State Key Laboratory of Oncogenes and Related Genes,Department of Oncology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Breast Surgery,Shanxi Cancer Hospital,Chinese Academy of Medical Sciences,Taiyuan,Shanxi,China;Department of Medical Ultrasound,Shanghai Tenth People's Hospital,Tongji University Cancer Center,School of Medicine,Tongji University,Shanghai,China;Precision Research Center for Refractory Diseases,Institute for Clinical Research,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;Department of Pathology,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,China;State Key Laboratory of Membrane Biology,Tsinghua-Peking University Joint Center for Life Sciences,School of Life Science,Tsinghua University,Beijing,China;State Key Laboratory of Genetic Engineering,School of Life Sciences,Fudan University,Shanghai,China
Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity
Ying Gao;Xueping Zheng;Boyang Chang;Yujie Lin;Xiaodan Huang;Wen Wang;Shirong Ding;Weixiang Zhan;Shang Wang;Beibei Xiao;Lanqing Huo;Youhui Yu;Yilin Chen;Run Gong;Yuanzhong Wu;Ruhua Zhang;Li Zhong;Xin Wang;Qiuyan Chen;Song GaoHu;Zhengfan Jiang;Denghui Wei;Tiebang Kang-Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China,Collaborative Innovation Center for Cancer Medicine,Guangzhou,Guangdong,China;Department of Interventional Radiology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong,China;Department of Abdominal Oncology,The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-sen University,Zhuhai,Guangdong,China;Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education,School of Life Sciences,Peking University,Beijing,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。